Page last updated: 2024-08-17

spironolactone and aromasil

spironolactone has been researched along with aromasil in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hartmann, RW; Hu, Q; Yin, L	1

Reviews

1 review(s) available for spironolactone and aromasil

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for spironolactone and aromasil

Article	Year
3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2. PloS one, 2012, Volume: 7, Issue:11 Topics: Algorithms; Androstadienes; Aromatase Inhibitors; Catalytic Domain; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Design; Enalapril; Eplerenone; Fadrozole; Humans; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Conformation; Spironolactone; Structure-Activity Relationship; Temperature	2012

Article

Year

3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2.

PloS one, 2012, Volume: 7, Issue:11

Topics: Algorithms; Androstadienes; Aromatase Inhibitors; Catalytic Domain; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Design; Enalapril; Eplerenone; Fadrozole; Humans; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Conformation; Spironolactone; Structure-Activity Relationship; Temperature

2012